From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Supplement
Last verified
June 4, 2026
SynergyEmerging evidence
What is happening. Fisetin and quercetin are both flavonoid senolytic candidates with overlapping antioxidant and anti-inflammatory mechanisms, and they are frequently studied together in the senolytic literature.
Mechanism. Both are flavonoids acting on overlapping antioxidant (Nrf2), anti-inflammatory (NF-kB), and senescence-related pathways; quercetin is the flavonoid used in human dasatinib-plus-quercetin senolytic trials, while fisetin senolytic data are mainly from aged-mouse studies.
Recommendation. May be combined within typical supplemental doses. Combined senolytic benefit in humans is not established, so do not assume additive clinical effects.
Stack Score
How it moves the number.
Effect on the composite score
If both Fisetin and Quercetin are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
2- 1Yousefzadeh MJ et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018.Needs sourceNo link
- 2Gorgoulis V et al. Cellular senescence: Defining a path forward. Cell. 2019.Needs sourceNo link